National Council for Prescription Drug Programs indexing - billing unit
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-13
- Label type
- Indexing - Billing Unit
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 03:22:51
Label at a glance#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 64764-254-03 | EA - Each | 64764-254 | ccdc0409-5cee-49e5-8466-1464f4cc4670 | 1 | 2013-02-13 |
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 64764-254 | 64764-254-03 |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022426-001 | OSENI | ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE | EQ 25MG BASE;EQ 15MG BASE | TABLET / ORAL | RLD | 2013-01-25 | |
| N022426-002 | OSENI | ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE | EQ 25MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | |
| N022426-003 | OSENI | ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE | EQ 25MG BASE;EQ 45MG BASE | TABLET / ORAL | RLD, RS | 2013-01-25 | |
| N022426-004 | OSENI | ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE | EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | |
| N022426-005 | OSENI | ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE | EQ 12.5MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | |
| N022426-006 | OSENI | ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE | EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022426-001 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | |
| N022426-001 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | |
| N022426-002 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | |
| N022426-002 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | |
| N022426-003 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | |
| N022426-003 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | |
| N022426-004 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | |
| N022426-004 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | |
| N022426-005 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | |
| N022426-005 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | |
| N022426-006 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | |
| N022426-006 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022426-001 | OSENI | EQ 25MG BASE;EQ 15MG BASE | TABLET / ORAL | RLD | 2013-01-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-002 | OSENI | EQ 25MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-003 | OSENI | EQ 25MG BASE;EQ 45MG BASE | TABLET / ORAL | RLD, RS | 2013-01-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-004 | OSENI | EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-005 | OSENI | EQ 12.5MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-006 | OSENI | EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-001 | OSENI | EQ 25MG BASE;EQ 15MG BASE | TABLET / ORAL | RLD | 2013-01-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-002 | OSENI | EQ 25MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-003 | OSENI | EQ 25MG BASE;EQ 45MG BASE | TABLET / ORAL | RLD, RS | 2013-01-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-004 | OSENI | EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-005 | OSENI | EQ 12.5MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-006 | OSENI | EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-001 | OSENI | EQ 25MG BASE;EQ 15MG BASE | TABLET / ORAL | RLD | 2013-01-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-002 | OSENI | EQ 25MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-003 | OSENI | EQ 25MG BASE;EQ 45MG BASE | TABLET / ORAL | RLD, RS | 2013-01-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-004 | OSENI | EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-005 | OSENI | EQ 12.5MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-006 | OSENI | EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022426-001 | OSENI | EQ 25MG BASE;EQ 15MG BASE | TABLET / ORAL | RLD | 2013-01-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022426-002 | OSENI | EQ 25MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022426-003 | OSENI | EQ 25MG BASE;EQ 45MG BASE | TABLET / ORAL | RLD, RS | 2013-01-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022426-004 | OSENI | EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022426-005 | OSENI | EQ 12.5MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022426-006 | OSENI | EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022426-001 | OSENI | EQ 25MG BASE;EQ 15MG BASE | TABLET / ORAL | RLD | 2013-01-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022426-002 | OSENI | EQ 25MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022426-003 | OSENI | EQ 25MG BASE;EQ 45MG BASE | TABLET / ORAL | RLD, RS | 2013-01-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022426-004 | OSENI | EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022426-005 | OSENI | EQ 12.5MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022426-006 | OSENI | EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022426-001 | OSENI | EQ 25MG BASE;EQ 15MG BASE | TABLET / ORAL | RLD | 2013-01-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022426-002 | OSENI | EQ 25MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022426-003 | OSENI | EQ 25MG BASE;EQ 45MG BASE | TABLET / ORAL | RLD, RS | 2013-01-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022426-004 | OSENI | EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022426-005 | OSENI | EQ 12.5MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022426-006 | OSENI | EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022426-001 | OSENI | EQ 25MG BASE;EQ 15MG BASE | TABLET / ORAL | RLD | 2013-01-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022426-002 | OSENI | EQ 25MG BASE;EQ 30MG BASE | TABLET / ORAL | RLD | 2013-01-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022426-003 | OSENI | EQ 25MG BASE;EQ 45MG BASE | TABLET / ORAL | RLD, RS | 2013-01-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022426-004 | OSENI | EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-01-25 | b8a1b40f171c… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022426-001 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-001 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-002 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-002 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-003 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-003 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-004 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-004 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-005 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-005 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-006 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022426-006 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-001 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-001 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-002 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-002 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-003 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-003 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-004 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-004 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-005 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-005 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-006 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022426-006 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-001 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-001 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-002 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-002 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-003 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-003 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-004 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-004 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-005 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-005 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-006 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022426-006 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022426-001 | 8173663 | 2025-03-15 | U-1338 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022426-001 | 8288539 | 2025-03-15 | Drug substance | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022426-001 | 7807689 | 2028-06-27 | U-1337 | Drug substance, Drug product | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022426-001 | 8637079 | 2029-06-04 | Drug product | 2014-02-13 | 31067a03dcf5… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N022426-001 | M-177 | 2019-04-05 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022426-002 | M-177 | 2019-04-05 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022426-003 | M-177 | 2019-04-05 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022426-004 | M-177 | 2019-04-05 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022426-005 | M-177 | 2019-04-05 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022426-006 | M-177 | 2019-04-05 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | N022426-001 | M-177 | 2019-04-05 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022426-002 | M-177 | 2019-04-05 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022426-003 | M-177 | 2019-04-05 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022426-004 | M-177 | 2019-04-05 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022426-005 | M-177 | 2019-04-05 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022426-006 | M-177 | 2019-04-05 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N022426-001 | M-177 | 2019-04-05 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022426-002 | M-177 | 2019-04-05 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022426-003 | M-177 | 2019-04-05 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022426-004 | M-177 | 2019-04-05 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022426-005 | M-177 | 2019-04-05 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022426-006 | M-177 | 2019-04-05 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N022426-001 | M-177 | 2019-04-05 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022426-002 | M-177 | 2019-04-05 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022426-003 | M-177 | 2019-04-05 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022426-004 | M-177 | 2019-04-05 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022426-005 | M-177 | 2019-04-05 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022426-006 | M-177 | 2019-04-05 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OSENI | ALOGLIPTIN AND PIOGLITAZONE | Takeda Pharmaceuticals America, Inc. | 4c619ed9-fe3e-4158-9938-80c6c3493d55 | 2025-02-28 | Boxed warning, Warnings, Adverse reactions | 64764-254-03 64764025403 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.